Aneurysmal subarachnoid hemorrhage prognostic decision making algorithm using classification and regression tree analysis

Similar documents
(aneurysmal subarachnoid hemorrhage, 17%~60% :SAH. ,asah , 22%~49% : Willis. :1927 Moniz ;(3) 2. ischemic neurological deficit,dind) SAH) SAH ;(6)

Definition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure

Ischemia cerebrale dopo emorragia subaracnoidea Vasospasmo e altri nemici

Correlation of revised fisher scale with clinical

Prognostic Factors for Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage

Clinical outcome prediction in aneurysmal subarachnoid hemorrhage Alterations in brain body interface

Age-Associated Vasospasm in Aneurysmal Subarachnoid Hemorrhage

Quantitative Analysis of Hemorrhage Volume for Predicting Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials

NIH Public Access Author Manuscript J Am Coll Radiol. Author manuscript; available in PMC 2013 June 24.

Epidemiology And Treatment Of Cerebral Aneurysms At An Australian Tertiary Level Hospital

N E W T O N. Hänggi D, Etminan N, Macdonald RL, Steiger HJ, Mayer SA, Aldrich F, Diringer MN, Hoh BJ, Mocco J, Strange P, Faleck HJ, Miller M

Preoperative Grading Systems of Spontaneous Subarachnoid Hemorrhage

THE EFFICACY AND SAFETY OF CILOSTAZOL IN SUBARACHNOID HEMORRHAGE. A META- ANALYSIS OF RANDOMIZED AND NON RANDOMIZED STUDIES DR. MUHAMMAD F.

Neurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery)

Distal anterior cerebral artery (DACA) aneurysms are. Case Report

GLYCEMIC CONTROL IN NEUROCRITICAL CARE PATIENTS

Predictors of Symptomatic Vasospasm After Subarachnoid Hemorrhage: A Single Center Study of 457 Consecutive Cases

Neurointensive Care of Aneurysmal Subarachnoid Hemorrhage. Alejandro A. Rabinstein Department of Neurology Mayo Clinic, Rochester, USA

Guideline scope Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management

Intracranial aneurysms are being treated with increasing frequency. Treatment of Poor-Grade Subarachnoid Hemorrhage Trial

Summary of some of the landmark articles:

Method Hannah Shotton

Phenytoin versus Levetiracetam for Prevention of Early Posttraumatic Seizures: A Prospective Comparative Study

Th e rupture of intracranial aneurysms is the most. Prognostic value of histopathological findings in aneurysmal subarachnoid hemorrhage

How many patients with aneurysmal subarachnoid hemorrhage

WHITE PAPER: A GUIDE TO UNDERSTANDING SUBARACHNOID HEMORRHAGE

Clinical Analysis of Risk Factors Affecting Rebleeding in Patients with an Aneurysm. Gab Teug Kim, M.D.

a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)).

Neurosurgical Management of Stroke

7/18/2018. Cerebral Vasospasm: Current and Emerging Therapies. Disclosures. Objectives

TCD AND VASOSPASM SAH

Prognostic Significance of Hyponatremia Leukocytosis, Hypomagnesemia, and Fever after Aneurysmal Subarachnoid Hemorrhage

Long-Term Excess Mortality After Aneurysmal Subarachnoid Hemorrhage Patients With Multiple Aneurysms at Risk

Effectiveness of Diagnostic Strategies in Suspected Delayed Cerebral Ischemia A Decision Analysis

Subarachnoid Hemorrhage and Brain Aneurysm

Dual diagnostic catheter technique in the endovascular management of anterior communicating artery complex aneurysms

Current State of the Art

Predicting Breast Cancer Survival Using Treatment and Patient Factors

Subarachnoid Hemorrhage (SAH) Disclosures/Relationships. Click to edit Master title style. Click to edit Master title style.

Clinical trial registration no.: NCT (clinicaltrials.gov) / jns161301

Ischemic Stroke in Critically Ill Patients with Malignancy

11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care

Progress Review. Mervyn D.I. Vergouwen, MD, PhD; Rob J. de Haan, PhD; Marinus Vermeulen, MD, PhD; Yvo B.W.E.M. Roos, MD, PhD

Acute lung injury in patients with subarachnoid hemorrhage: Incidence, risk factors, and outcome

Canadian Best Practice Recommendations for Stroke Care 3.6 Acute Subarachnoid Hemorrhage

THREE HUNDRED AND ten TBI patients with a

Extent of subarachnoid hemorrhage and development of hydrocephalus

Small UIAs, <7 mm in diameter, uncommonly cause aneurysmal symptoms and are the most frequently detected incidentally.

Decompressive Hemicraniectomy in Acute Neurological Diseases

Table 3.1: Canadian Stroke Best Practice Recommendations Screening and Assessment Tools for Acute Stroke Severity

Angel J. Lacerda MD PhD, Daisy Abreu MD, Julio A. Díaz MD, Sandro Perez MD, Julio C Martin MD, Daiyan Martin MD.

Clinical Decision Rules to Rule Out Subarachnoid Hemorrhage for Acute Headache FREE

Clinically Significant Cardiac Arrhythmia in Patients with Aneurysmal Subarachnoid Hemorrhage

Albumin In SubArachnoid Hemorrhage: The ALISAH Study

Assessment of Vasospasm and Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Current concepts and Value of CT Perfusion and CT Angiography

TEMPORARY occlusion of the cerebral vasculature

Recombinant Factor VIIa for Intracerebral Hemorrhage

Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs

Mohamed Al-Khaled, MD,* Christine Matthis, MD, and J urgen Eggers, MD*

Coiling of ruptured and unruptured intracranial aneurysms

Correlation of Neurodevelopmental Outcome and brain MRI/EEG findings in term HIE infants

Canadian Stroke Best Practices Table 3.3A Screening and Assessment Tools for Acute Stroke

Aneurysmal subarachnoid hemorrhage in the elderly:

There is a national trend for accountable care and

Impact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid Hemorrhage

FVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial. Joseph P. Broderick, MD James Grotta, MD Jordan Elm, PhD

Received: 15 September 2014 /Accepted: 20 November 2014 /Published online: 6 December 2014 # Springer-Verlag Berlin Heidelberg 2014

Prognostic Factors in Patients who Underwent Aneurysmal Clipping due to Spontaneous Subarachnoid Hemorrhage

It has been speculated that the true natural course of

SAH READMISSIONS TO NCCU

Aneurysm Treatment <24 Versus h After Subarachnoid Hemorrhage

Predictors of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Cardiac Focus

Epilepsy after two different neurosurgical approaches

Endovascular coil embolization of ruptured intracranial. The Barrow Ruptured Aneurysm Trial. Clinical article

Position Statement. Enrollment and Randomization. ISAT Study Design. ISAT Results

Clinical Review of 20 Cases of Terson s Syndrome

A discussion of the optimal treatment of intracranial aneurysm rupture in elderly patients

The Worst Headache of My Life Hemorrhagic Stroke

Hypervolemic Versus Normovolemic Therapy in Patients with Ruptured Cerebral Aneurysm. Sung Don Kang, M.D., Ph.D., Yo Sik Kim, M.D., Ph.D.

A Less Invasive Approach for Ruptured Aneurysm with Intracranial Hematoma: Coil Embolization Followed by Clot Evacuation

What You Should Know About Cerebral Aneurysms

Sinus Venous Thrombosis

The Meaning of the Prognostic Factors in Ruptured Middle Cerebral Artery Aneurysm with Intracerebral Hemorrhage

Introduction. Keywords: Infrainguinal bypass; Prognosis; Haemorrhage; Anticoagulants; Antiplatelets.

Citation Characteristics of Research Published in Emergency Medicine Versus Other Scientific Journals

Risk of thromboembolic events with endovascular cooling catheters in patients with subarachnoid hemorrhage

I T IS generally agreed that the surgical risk

A ccurate prediction of outcome in the acute and

Relationship between serum and csf glucose in subarachnoid hemorrhage

Fundus findings in spontaneous subarachnoid hemorrhage and their correlation with neurologic characteristics

ORIGINAL CONTRIBUTION. Cerebrospinal Fluid Creatine Kinase BB Isoenzyme Activity and Outcome After Subarachnoid Hemorrhage

Racial differences in demographics, acute complications, and outcomes in patients with subarachnoid hemorrhage: a large patient series

Surgical Management of Stroke Brandon Evans, MD Department of Neurosurgery

acute-onset, severe, recurrent reversible vasoconstriction

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

Nicolas Bianchi M.D. May 15th, 2012

TITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian

Transcription:

OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA Original Article Aneurysmal subarachnoid hemorrhage prognostic decision making algorithm using classification and regression tree analysis Benjamin W. Y. Lo, Hitoshi Fukuda 1, Mark Angle, Jeanne Teitelbaum, R. Loch Macdonald 2, Forough Farrokhyar 3, Lehana Thabane 4, Mitchell A. H. Levine 5 Departments of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada, 1 Departments of Neurosurgery, Kurashiki Central Hospital, Kyoto University, Okayama, Japan, 2 Division of Neurosurgery, St. Michael s Hospital, University of Toronto, Toronto, Ontario, Canada, 3 Department of Surgery, Department of Clinical Epidemiology and Biostatistics, 4 Department of Clinical Epidemiology and Biostatistics, 5 Department of Medicine, Division of Clinical Pharmacology, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada E mail: *Benjamin W. Y. Lo benjamin.lo@mcgill.ca; Hitoshi Fukuda fukudaharpseal@gmail.com; Mark Angle mark.angle@muhc.mcgill.ca; Jeanne Teitelbaum jteitelbaum@hotmail.com; R. Loch Macdonald macdonaldlo@smh.ca; Forough Farrokhyar farrokh@mcmaster.ca; Lehana Thabane thabanl@mcmaster.ca; Mitchell A. H. Levine levinem@mcmaster.ca *Corresponding author Received: 15 March 16 Accepted: 01 June 16 Published: 07 July 16 Abstract Background: Classification and regression tree analysis involves the creation of a decision tree by recursive partitioning of a dataset into more homogeneous subgroups. Thus far, there is scarce literature on using this technique to create clinical prediction tools for aneurysmal subarachnoid hemorrhage (SAH). Methods: The classification and regression tree analysis technique was applied to the multicenter Tirilazad database (3551 patients) in order to create the decision making algorithm. In order to elucidate prognostic subgroups in aneurysmal SAH, neurologic, systemic, and demographic factors were taken into account. The dependent variable used for analysis was the dichotomized Glasgow Outcome Score at 3 months. Results: Classification and regression tree analysis revealed seven prognostic subgroups. Neurological grade, occurrence of post admission stroke, occurrence of post admission fever, and age represented the explanatory nodes of this decision tree. Split sample validation revealed classification accuracy of 79% for the training dataset and 77% for the testing dataset. In addition, the occurrence of fever at 1 week post aneurysmal SAH is associated with increased odds of post admission stroke (odds ratio: 1.83, 95% confidence interval: 1.56 2.45, P < 0.01). Conclusions: A clinically useful classification tree was generated, which serves as a prediction tool to guide bedside prognostication and clinical treatment decision making. This prognostic decision making algorithm also shed light on the complex interactions between a number of risk factors in determining outcome after aneurysmal SAH. Access this article online Website: www.surgicalneurologyint.com DOI: 10.4103/2152-7806.185786 Quick Response Code: Key Words: Aneurysmal subarachnoid hemorrhage, brain body interactions, classification and regression tree analysis, prognostic decision making INTRODUCTION Neurologic outcome after aneurysmal subarachnoid hemorrhage (SAH) is influenced by a number of complex brain body associations, including both non treatment and treatment related demographic, neurologic, and systemic factors. For bedside prognostication and clinical This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. For reprints contact: reprints@medknow.com How to cite this article: Lo BW, Fukuda H, Angle M, Teitelbaum J, Macdonald RL, Farrokhyar F, et al. Aneurysmal subarachnoid hemorrhage prognostic decisionmaking algorithm using classification and regression tree analysis. Surg Neurol Int 2016;7:73. http://surgicalneurologyint.com/aneurysmal-subarachnoid-hemorrhage-prognosticdecision-making-algorithm-using-classification-and-regression-tree-analysis/ 2016 Surgical Neurology International Published by Wolters Kluwer - Medknow

decision making, a prediction tool is useful as an adjunct to complement clinical opinion and judgment. [8,9] One of the most frequently used measures of global function outcomes after aneurysmal SAH is the Glasgow Outcome Score (GOS). It is graded into five subgroups, including good recovery, moderate disability but functional independence, functional dependence with severe disability, persistent vegetative state, and death. This scale can be easily and accurately administered, is reliable as self or surrogate reporting tool, and correlates well with neuropsychological test measures. Subtleties to changes in function can be captured by its extended version, as well as other neuropsychological and quality of life outcome scores. [6,16] Classification and regression tree analysis is a statistical technique that involves creation of a decision tree by recursive partitioning of a dataset into more homogeneous subgroups. At each node, the best possible split for each variable is found by minimizing the impurity of subsequent daughter nodes. This technique prevents overfitting by pruning terminal nodes or leaves such that a decision tree is found with the smallest error rates. In addition, model performance can be enhanced by split sample validation techniques. Classification and regression tree analysis is a statistical technique that takes into account non linear and high order interactions. It can handle large datasets with missing data, as well as high dimensionality. [1,2,11] Objectives Using data from placebo and treatment arms of five clinical trials of Tirilazad, we aim to create a prognostic decision making algorithm for aneurysmal SAH patients using the classification and regression tree analysis technique. In addition, model performance will be evaluated. MATERIALS AND METHODS The Tirilazad database was used to investigate prognostic subgroups for outcome prediction in aneurysmal SAH patients. The Statistical Package for the Social Sciences (IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp) was used to create the classification and regression decision tree. Candidate predictors included independent variables that reached a probability of 0.10 in univariate logistic regression analysis, including 1. Hospital admission neurological (Hunt and Hess) grade [1 asymptomatic, 2 headaches, cranial nerve palsy, 3 mild focal deficit, 4 stupor, moderate to severe hemiparesis, 5 deep coma], 2. Age (years), 3. Time to surgery (hours), 4. Occurrence of post admission fever on day 8, 5. Aneurysm size ( 12 mm or >12 mm), 6. Presence of angiographic vasospasm on hospital admission, 7. Presence of intraventricular hemorrhage, 8. Development of cerebral edema, 9. Presence of intracerebral hemorrhage, 10. History of hypertension, 11. History of myocardial infarction, 12. Occurrence of stroke post admission, 13. Prior episode of SAH, 14. Location of aneurysm, 15. Development of vasospasm during course of treatment, and 16. Development of seizures requiring antiepileptic medications. The dependent variable used for the analysis was the dichotomized GOS at three months, where good outcome represents functional independence (GOS 5 and 4) and poor outcome represents functional dependence (GOS 3), persistent vegetative state (GOS 2), or death (GOS 1). Statistical power was ensured by having effective sample size of more than 10 participants per variable, and at least 10 patients per final subgroup. [1,2,11,17] For preparing the decision tree, the Gini index splitting rule was used to decrease variance between classes through reduction of entropy where the largest categories were split into separate subgroups. Overfitting was avoided by using tree pruning. [1,2,11,17] Decision trees were generated with training and testing datasets, with percentages of favorable outcome reported in each terminal prognostic subgroup. Split sample analysis (70% training and 30% testing) was used to examine model performance, with reports of classification accuracy, risk estimate, and standard error for each decision tree. Univariate models using Chi square analyses were performed to investigate the associations between explanatory variables generated in the classification trees. RESULTS Patient selection and participation in the Tirilazad trials are summarized in Figure 1. In the Tirilazad patient populations, unfavorable outcome (functional dependence, persistent vegetative state, and death) at 3 months after aneurysmal SAH was observed in 1061 (30%) patients. Classification trees describing the relationships between neurological outcome and explanatory factors in aneurysmal SAH were generated using the training dataset [Figure 2] and testing dataset [Figure 3]. Figures 2 and 3 demonstrate seven terminal prognostic subgroups with the same node ranking order according to the percentages of unfavorable outcomes,

Figure 1: Patient selection and participation in the Tirilazad trials with percentage differences between the two decision trees ranging from 1.3 to 7.8%. Seven terminal prognostic subgroups are illustrated as follows: 1. Good admission neurological grade (Hunt and Hess grades 1 or 2), absent post admission stroke (Node #3) 8.7% unfavorable outcome (training dataset) and 7.4% unfavorable outcome (testing dataset), 2. Poor admission neurological grades (Hunt and hess grades 3 or 4), absent post admission stroke, absent post admission fever (Node #10) 33.6% unfavorable outcome (training dataset) and 37.4% unfavorable outcome (testing dataset), 3. Good admission neurological grades, post admission stroke, age <58.5 years (Node #7) 38.3% unfavorable outcome (training dataset) and 43.8% unfavorable outcome (testing dataset), Figure 2: Aneurysmal subarachnoid hemorrhage classification tree using training data set. [For Node 0 (Outcome), 0 = favorable outcome [Glasgow Outcome Score (GOS) 5 and 4], 1 = unfavorable outcome (GOS 3, 2, and 1). For Nodes 1 12, 0 = absent, 1 = present.]

Figure 3: Aneurysmal subarachnoid hemorrhage classification tree using testing data set. [For Node 0 (Outcome), 0 = favorable outcome [Glasgow Outcome Score (GOS) 5 and 4)], 1 = unfavorable outcome (GOS 3, 2, and 1). For Nodes 1 12, 0 = absent, 1 = present.] 4. Poor admission neurological grades, absent post admission stroke, development of post admission fever (Node #12) 44.6% unfavorable outcome (training dataset) and 48.6% unfavorable outcome (testing dataset), 5. Good admission neurological grades, post admission stroke, age >58.5 years (Node #8) 59.4% unfavorable outcome (training dataset) and 54.7% unfavorable outcome (testing dataset), 6. Poor admission neurological grade (Hunt and Hess grade 5), absent post admission stroke, development of post admission fever (Node #11) 69.7% unfavorable outcome (training dataset) and 61.9% unfavorable outcome (testing dataset), and 7. Poor admission neurological grades, post admission stroke (Node #6) 75.4% unfavorable outcome (training dataset) and 72.9% unfavorable outcome (testing dataset). The classification and regression tree model generated using the training dataset had a classification accuracy of 79%, risk estimate of 0.21, with a standard error of 0.008. The model generated using the testing dataset had a classification accuracy of 77%, risk estimate of 0.23, and a standard error of 0.01. The occurrence of fever at 1 week post aneurysmal rupture is associated with increased odds of post admission stroke (odds ratio (OR): 1.83, 95% confidence interval (CI): 1.56 2.45, P < 0.01).

Table 1 shows a clinical prognostic decision making algorithm for aneurysmal SAH patients with prognostic subgroups based on the classification and regression tree derived from the Tirilazad database. DISCUSSION Clinical prediction tools facilitate the process of prognostication and clinical decision making for both clinicians and patient families. The current classification and regression tree has seven terminal prognostic subgroups and makes use of the two most frequently retained clinical prognostic factors for long term neurologic outcome, namely, neurological grade [3,4,10,12,13,14,15] and age. [3,5,10,12,13,14,15] It also demonstrates the significance of both post admission stroke and fever in outcome prediction. In the present study, the occurrence of post admission stroke increases the proportion of unfavorable neurologic outcome in aneurysmal SAH patients originally presenting with favorable admission neurological grades by 30%. In our prior analysis of the Tirilizad database, multivariable logistic regression analysis demonstrated that post admission stroke increases the odds of poor neurological outcome in aneurysmal SAH patients by four fold (OR: 4.03, 95% CI: 2.11 7.69, P < 0.01). Patients experiencing vasospasm are at an increased risk of post admission strokes. In addition, several secondary injury cascade events may predispose these patients to post admission strokes, including: (1) Microthrombi formation, (2) cortical spreading depression, (3) microvascular constriction, (4) proliferation of pro inflammatory cascade, (5) presence of blood brain barrier disruption, and (6) inadequate collateral circulation. [7,9] Several contemporary neurocritical care strategies are used to decrease the likelihood of post admission strokes. They include: (1) The use of milrinone, an inotropic vasodilator with anti inflammatory properties, to prevent and treat vasospasm, (2) early decompressive craniectomy in patients with refractory increased intracranial pressures associated with cerebral edema, and (3) monitoring and treating seizures. Fever is often a clinical indicator of neurological deterioration because it also triggers events in the secondary cascade of neurological injury. An epileptic aneurysmal SAH patient who develops post admission fever has an increased odds of poor outcome by a factor of 2.4 (OR: 2.4, 95% CI: 1.86 3.06, P < 0.01). The various causes of post admission late onset fevers, including nosocomial infections, central neurological injury, thromboembolic events, and drug drug interactions, can also lead to neurological complications, including increased intracranial pressures, cerebral edema, and post admission strokes. [7,9] The occurrence of fever at 1 week post hospital admission is associated with increased odds of post admission strokes (OR: 1.83, 95% CI: 1.56 2.15, P < 0.01), including vasospasm induced delayed strokes. Aggressive symptomatic control and rigorous search for underlying etiology are, therefore, warranted. Limitations The decision tree algorithm presented in this study was created using the Tirilazad database whereby prospective data was gathered to test an intervention, rather than for clinical prognostic purposes. Since the conduct Table 1: Clinical prognostic decision making algorithm in aneurysmal subarachnoid hemorrhage, with prognostic subgroups based on classification and regression tree derived from the Tirilazad database Admission neurological grade Age=58.5 years Post admission fever Post admission stroke Unfavorable outcome (%) Unfavorable outcome category Poor Older Present Present 75.9 >75% very high Poor Older Absent Present 73.6 50-75% high Poor Younger Present Present 66.9 Good Older Present Present 63.2 Poor Older Present Absent 56.6 Poor Younger Absent Present 55.4 Good Older Absent Present 44.0 25-50% intermediate Poor Older Absent Absent 41.5 Good Younger Present Present 39.0 Poor Younger Present Absent 39.0 Good Younger Absent Present 25.7 Good Older Present Absent 18.5 <25% low Poor Younger Absent Absent 17.4 Good Older Absent Absent 14.3 Good Younger Present Absent 7.9 Good Younger Absent Absent 2.0

of the clinical trials of Tirilazad, there have been advances in the surgical treatment and neurocritical care management of aneurysmal SAH patients. Despite variations in management at different centers, terminal prognostic subgroups depicted remain clinically relevant in a contemporary setting because they encompass frequently encountered factors including neurological grade, age, post admission stroke, and fever. In this study, split validation technique was used to enhance model generalizability. Further investigations can make use of the classification and regression technique with external patient cohorts to further examine model generalizability. CONCLUSIONS Clinical outcome after aneurysmal SAH may be influenced by interactions among a number of brain body associations. Classification tree algorithm serves as a useful tool for prognostic decision making. The prognostic subgroups demonstrated the interplay of various underlying pathophysiologic mechanisms which, together, may adversely influence long term neurologic outcome after aneurysmal SAH. The classification tree generated in this article increases clinician and patient family awareness of the various demographic, neurologic, and systemic prognostic factors, which are pertinent for initial prognostication, namely, admission neurological grade and patient age. It also alerts the clinician regarding two important brain body associations, including the occurrence of fever and delayed strokes, which may arise during hospitalization severely affecting patient outcomes. The clinician is, then, encouraged to tailor various treatment efforts to prevent and treat these, as well as other alterations in the brain body interface in order to maximize the chances of survival and recovery after aneurysmal subarachnoid hemorrhage. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest. REFERENCES 1. Breiman L. Classification and regression trees. Belmont, CA: Wadsworth; 1984. 2. De ath G, Fabricius K. Classification and regression trees: A powerful yet simple technique for ecological data analysis. Ecology 2000;81:3178 92. 3. Germanson T, Lanzino G, Kongable G, Torner J, Kassell N. Risk classification after aneurysmal subarachnoid hemorrhage. Surg Neurol 1998;49:155 63. 4. Kahn J, Caldwell E, Deem S, Newell D, Heckbert S, Rubenfeld G. Acute lung injury in patients with subarachnoid hemorrhage: Incidence, risk factors and outcome. Crit Care Med 2006;34:196 202. 5. Karamanakos PN, von Und Zu Fraunberg M, Bendel S, Huttunen T, Kurki M, Hernesniemi J, et al. Risk factors for three phases of 12 month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage. World Neurosurg 2012;78:631 9. 6. Lo B, Stojic F, Spears J, Schweizer T, Macdonald R. Clinical outcomes, stroke trials and cognitive outcome. In: The Behavioral Consequences of Stroke. New York: Springer; 2014. pp. 283 314. 7. Lo B, Fukuda H. Pathophysiology of brain somatic interactions in aneurysmal subarachnoid hemorrhage Review and update. Brain Disord Ther 2015;4:183. 8. Lo BW, Fukuda H, Nishimura Y, Farrokhyar F, Thabane L, Levine MA. Systematic review of clinical prediction tools and prognostic factors in aneurysmal subarachnoid hemorrhage. Surg Neurol Int 2015;6:135. 9. Lo BW, Fukuda H, Nishimura Y, Macdonald RL, Farrokhyar F, Thabane L, et al. Pathophysiologic mechanisms of brain body associations in ruptured brain aneurysms: A systematic review. Surg Neurol Int 2015;6:136. 10. McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2007;107:1080 5. 11. Moisen G. Classification and regression trees. In: Encyclopedia of Ecology. Oxford, UK: Elsevier; 2008. pp. 582 8. 12. Ogilvy CS, Cheung AC, Mitha AP, Hoh BL, Carter BS. Outcomes for surgical and endovascular management of intracranial aneurysms using a comprehensive grading system. Neurosurgery 2006;59:1037 42. 13. Rabinstein AA, Friedman JA, Nichols DA, Pichelmann MA, McClelland RL, Manno EM, et al. Predictors of outcome after endovascular treatment of cerebral vasospasm. AJNR Am J Neuroradiol 2004;25:1778 82. 14. Risselada R, Lingsma HF, Bauer Mehren A, Friedrich CM, Molyneux AJ, Kerr RS, et al. Prediction of 60 day case fatality after aneurysmal subarachnoid haemorrhage: Results from the International Subarachnoid Aneurysm Trial (ISAT). Eur J Epidemiol 2010;25:261 6. 15. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2315 21. 16. Sanchez C, Ogilvy C, Carter B. Outcomes studies in cerebrovascular neurosurgery. Neurosurg Focus 2007;22:E11. 17. Yohannes Y, Webb P. Classification and regression trees, CART: A user manual for identifying indicators of vulnerability to famine and chronic food insecurity. Washington, D.C.: International Food Policy Research Institute, 1999.